News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Cavco Industries will report fiscal 2027 Q1 results after market close on July 30, followed by a management webcast on July 31.
  • Cavco is a U.S. factory-built homes and modular commercial structures manufacturer with finance and insurance subsidiaries.
  • Cavco results will act as a near-term signal for manufactured-housing demand and related finance performance.
  • FANUY (FANUC ADR) is promoted as a tactical buy-the-dip trade supported by AI and robotics partnership momentum.
  • Technically, FANUY has pulled below short- and mid-term moving averages, creating a defined-risk long setup with 180-day catalysts.

Latest Articles

Meta: From 'Zuckerberg Discount' to Premium - A Tactical Buy at $630

Meta: From 'Zuckerberg Discount' to Premium - A Tactical Buy at $630

Meta is trading below where its fundamentals and cash-generation suggest it should. Strong free cash flow ($48.25B), a lean balance sheet (debt/equity ~0.24), and accelerating AI-driven product initiatives create a pathway for the market to remove the so-called 'Zuckerberg discount' and award a premium multiple. This is a long-term trade idea with …

Maris-Tech Unveils Venus-Space, Expanding AI-Powered Edge Video Solutions to Low Earth Orbit Nano Satellites

Maris-Tech Unveils Venus-Space, Expanding AI-Powered Edge Video Solutions to Low Earth Orbit Nano Satellites

Maris-Tech Ltd. has announced the development of Venus-Space, an advanced AI-powered edge video processing platform tailored for low Earth orbit nano satellites. Leveraging upgraded capabilities from its Venus-Pro system, Venus-Space enables ultra-high-resolution video acquisition, onboard AI inference, and real-time streaming, significantly reduci…

Stocks End Week at Records as Market Awaits Jobs Report and Broadcom Results

Stocks End Week at Records as Market Awaits Jobs Report and Broadcom Results

U.S. equity benchmarks finished Friday at intraday record levels, capping a robust month driven by gains in technology shares. Dell Technologies delivered an outsized single-day gain after topping revenue and earnings expectations and boosting its full-year outlook. Investors will focus next week on the May employment report and quarterly results f…

Rezolve Ai Positioned at the Heart of the AI Transformation of $30 Trillion Global Retail, Reiterates $360M+ FY26 Revenue Guidance

Rezolve Ai Positioned at the Heart of the AI Transformation of $30 Trillion Global Retail, Reiterates $360M+ FY26 Revenue Guidance

Rezolve Ai PLC, trading on NASDAQ as RZLV, reaffirmed its FY26 revenue guidance of approximately $360 million, demonstrating strong confidence backed by accelerating enterprise adoption and conversion of its commercial pipeline. The company reported Q1 2026 revenue of $60 million, surpassing its total 2025 revenue, highlighting significant growth d…

Wave Life Sciences to Present at Upcoming Investor Conferences

Wave Life Sciences to Present at Upcoming Investor Conferences

Wave Life Sciences Ltd., a clinical-stage biotechnology company specializing in RNA medicines, announced that its CEO will participate in two major healthcare investor conferences in June 2026. These events provide an opportunity to showcase the company's innovative RNA platform and diverse clinical pipeline targeting various genetic diseases.

Plexus Issues Fiscal 2025 Sustainability Report and Announces Transition to Absolute Emission Reduction Targets

Plexus Issues Fiscal 2025 Sustainability Report and Announces Transition to Absolute Emission Reduction Targets

Plexus Corp. has released its Fiscal 2025 Sustainability Report, marking a strategic move from intensity-based to absolute emission reduction targets. The company commits to reducing emissions by 2033, has doubled its zero waste sites, enhanced social impact contributions, and improved team member well-being programs, underscoring its dedication to…

IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026

IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026

IN8bio announced updated clinical data showing that repeat dosing of DeltEx DRI, a gamma-delta T cell therapy, combined with standard-of-care treatment significantly improved median progression-free and overall survival in newly diagnosed glioblastoma patients. Median overall survival exceeded 19.5 months, roughly 48% longer than with standard care…

JET.AI ANNOUNCES LEADING INDEPENDENT PROXY ADVISORY FIRM GLASS LEWIS RECOMMENDS STOCKHOLDERS VOTE “FOR” THE PROPOSED MERGER

JET.AI ANNOUNCES LEADING INDEPENDENT PROXY ADVISORY FIRM GLASS LEWIS RECOMMENDS STOCKHOLDERS VOTE “FOR” THE PROPOSED MERGER

Jet.AI Inc., a NASDAQ-listed company that provides high-performance GPU infrastructure and AI cloud services, announced that leading proxy advisory firm Glass Lewis recommends stockholders vote in favor of the company's proposed merger with flyExclusive. The Jet.AI Board supports this recommendation and urges stockholders to vote promptly to comple…

Fast Track Entertainment Brings Dream Cruises’ 10th Anniversary Celebrity Strategy to Life with Chef Tommie Lee Onboard ‘Genting Dream’

Fast Track Entertainment Brings Dream Cruises’ 10th Anniversary Celebrity Strategy to Life with Chef Tommie Lee Onboard ‘Genting Dream’

Fast Track Group, a Nasdaq-listed entertainment and event management company, announced a multi-part celebrity partnership with Dream Cruises to celebrate its 10th anniversary. The campaign includes exclusive appearances by Chef Tommie Lee onboard the Genting Dream cruise, and upcoming wellness and entertainment components featuring South Korean fi…

Rocky Mountain Chocolate Factory Reports Fiscal Fourth Quarter and Full Year 2026 Financial Results

Rocky Mountain Chocolate Factory Reports Fiscal Fourth Quarter and Full Year 2026 Financial Results

Rocky Mountain Chocolate Factory announced its fiscal fourth quarter and full year 2026 financial results, highlighting significant operational changes that led to improved product margins but lower overall revenue. The company continues to focus on operational efficiencies, enhancing data analytics, and franchise development despite reporting a ne…

reAlpha (NASDAQ: AIRE) to Host “AIRE Time With Mike” Fireside Chat Moderated by Benchmark Analyst Daniel Kurnos

reAlpha (NASDAQ: AIRE) to Host “AIRE Time With Mike” Fireside Chat Moderated by Benchmark Analyst Daniel Kurnos

reAlpha Tech Corp., an AI-driven real estate technology company listed on NASDAQ under ticker AIRE, will host a live X Spaces fireside chat featuring its CEO and CFO alongside a Benchmark analyst. The discussion will focus on housing market conditions, mortgage industry trends, AI applications in real estate, and reAlpha's strategic positioning.

National Healthcare Properties Provides Business Updates

National Healthcare Properties Provides Business Updates

National Healthcare Properties, Inc. reported significant growth in its SHOP acquisitions pipeline valued at approximately $279 million, expected to add over 1,200 units to its senior housing portfolio. Additionally, the company's Class A common stock will be included in the Russell 2000 and 3000 Indexes, reflecting its expanding market presence af…

INNOVATE Announces Successful Closing of Broadcasting Refinancing and Agrees to Partial Sale of Broadcasting

INNOVATE Announces Successful Closing of Broadcasting Refinancing and Agrees to Partial Sale of Broadcasting

INNOVATE Corp. announced the successful closing of a $105 million refinancing transaction for its broadcasting subsidiary HC2 Broadcasting Holdings Inc. Concurrently, INNOVATE entered into a definitive agreement to sell a 75% controlling interest in Broadcasting to CONX CORP, retaining 25% ownership. The transaction, subject to customary regulatory…

Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting

Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting

Fate Therapeutics showcased early Phase 1 clinical data for its off-the-shelf CAR T-cell therapy FT836 at the ASCO Annual Meeting, highlighting meaningful tumor reductions in KRAS wild-type metastatic colorectal cancer patients without the need for conditioning chemotherapy. The therapy utilizes novel Sword and Shield technology, enabling persisten…